✦ LIBER ✦

Second-line systemic therapy and emerging drugs for metastatic transitional-cell carcinoma of the urothelium

✍ Scribed by Guru Sonpavde; Cora N Sternberg; Jonathan E Rosenberg; Noah M Hahn; Matthew D Galsky; Nicholas J Vogelzang

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second-line systemic therapy for the tre

✍ Kruck, Stephan ;Bedke, Jens ;Kuczyk, Markus A ;Merseburger, Axel S 📂 Article 📅 2012 🏛 Expert Reviews 🌐 English ⚖ 473 KB

Phase II Trial of Pyrazoloacridine as Se

✍ Paul M. Dodd; John A. McCaffrey; Madhu Mazumdar; Evelyn Icasiano; Geralyn Higgin 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 50 KB

Emerging and second line therapies for t

✍ Phillip PARENTE; Francis PARNIS; Howard GURNEY 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

Small molecule targeted therapies for th

✍ Dranitsaris, George; Schmitz, Susanne; Broom, Reuben J. 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 325 KB

81 Updated results of the phase 3 AXIS t

✍ B. Escudier; B.I. Rini; T.E. Hutson; M. Gore; S. Oudard; J. Tarazi; B. Rosbrook; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Small Molecule Targeted Therapies for th

✍ Dranitsaris, G.; Schmitz, S.; Broom, R.J. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB